Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.42 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.42 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.42 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.42 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 7/20 | 0.38 |
| ▸ | HTR2B | P41595 | 6/20 | 0.38 |
| ▸ | HTR2A | P28223 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17679251 | 0.91 | DRD2 (0.46) | RECQLTP53MDM2PRMT3CARM1 | |
| SCHEMBL18824255 | 0.75 | MAPK1 (0.46) | TP53PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL15461422 | 0.75 | PRCP (0.50) | RECQLTP53MDM2POLBGAA | |
| SCHEMBL11452553 | 0.74 | CHRNB2 (0.56) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| Hydrochloric Acid SCHEMBL3670802 | 0.74 | SIGMAR1 (0.44) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL819498 | 0.73 | TP53 (0.70) | RECQLTP53MDM2SIGMAR1POLB | |
| SCHEMBL4714894 | 0.73 | CHRNB2 (0.50) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL14472858 | 0.73 | RIPK1 (0.43) | RECQLPRMT3CARM1PRMT6PRMT1 | |
| Hydrochloric Acid SCHEMBL11786349 | 0.73 | KCNH2 (0.47) | ALDH1A1DRD2 | |
| Hydrochloric Acid SCHEMBL3670800 | 0.71 | P2RX7 (0.41) | SIGMAR1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150057466-A1 | Synthesis of Triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2015-02-26 | — | — | US | claimed |
| EP-1778618-B1 | SYNTHESIS OF TRIETHYLENETETRAMINES | PHILERA NEW ZEALAND LTD (NZ) | 2013-12-25 | — | — | EP | claimed |
| US-20120029203-A1 | Synthesis Of Triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2012-02-02 | — | — | US | claimed |
| US-7582796-B2 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | PROTEMIX CORPORATION LIMITED (NZ) | 2009-09-01 | — | — | US | claimed |
| EP-1778618-A4 | SYNTHESIS OF TRIETHYLENETETRAMINES | PROTEMIX CORP LTD (NZ) | 2008-07-16 | — | — | EP | claimed |
| EP-1778618-A2 | SYNTHESIS OF TRIETHYLENETETRAMINES | Protemix Corporation Limited (NZ) | 2007-05-02 | — | — | EP | claimed |
| WO-2006027705-A2 | SYNTHESIS OF TRIETHYLENETETRAMINES | PROTEMIX CORPORATION LIMITED (NZ) | 2006-03-16 | — | — | WO | claimed |
| US-20060041170-A1 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | PHILERA NEW ZEALAND LIMITED (NZ) | 2006-02-23 | — | — | US | claimed |
| US-11795150-B2 | Synthesis of triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2023-10-24 | — | — | US | disclosed |
| US-11795150-B2 | Synthesis of triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2023-10-24 | — | — | US | disclosed |
| US-11795150-B2 | Synthesis of triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2023-10-24 | — | — | US | disclosed |
| US-20200148647-A1 | Synthesis of Triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2020-05-14 | — | — | US | disclosed |
| US-20200148647-A1 | Synthesis of Triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2020-05-14 | — | — | US | disclosed |
| US-20170226064-A1 | Synthesis of Triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2017-08-10 | — | — | US | disclosed |
| US-7582796-B2 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | PROTEMIX CORPORATION LIMITED (NZ) | 2009-09-01 | — | — | US | disclosed |
| US-7582796-B2 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | PROTEMIX CORPORATION LIMITED (NZ) | 2009-09-01 | — | — | US | disclosed |
| EP-1778618-A4 | SYNTHESIS OF TRIETHYLENETETRAMINES | PROTEMIX CORP LTD (NZ) | 2008-07-16 | — | — | EP | disclosed |
| EP-1778618-A2 | SYNTHESIS OF TRIETHYLENETETRAMINES | Protemix Corporation Limited (NZ) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006027705-A2 | SYNTHESIS OF TRIETHYLENETETRAMINES | PROTEMIX CORPORATION LIMITED (NZ) | 2006-03-16 | — | — | WO | disclosed |
| US-20060041170-A1 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | PHILERA NEW ZEALAND LIMITED (NZ) | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795150-B2 | Synthesis of triethylenetetramines | PNMT, TES, TPR | RECQL 1538/4885TP53 1755/4885MDM2 920/4885 |
| US-20170226064-A1 | Synthesis of Triethylenetetramines | PNMT, TES, TPR | RECQL 1538/4885TP53 1755/4885MDM2 920/4885 |
| US-20120029203-A1 | Synthesis Of Triethylenetetramines | PNMT, TES, TPR | RECQL 1538/4885TP53 1755/4885MDM2 920/4885 |
| US-20150057466-A1 | Synthesis of Triethylenetetramines | PNMT, TES, TPR | RECQL 1538/4885TP53 1755/4885MDM2 920/4885 |
| US-20200148647-A1 | Synthesis of Triethylenetetramines | PNMT, TES, TPR | RECQL 1538/4885TP53 1755/4885MDM2 920/4885 |
| US-20060041170-A1 | starting the reaction of alkylating ethylenediamine with formaldehyde to form pure triethylenetetramine; salt formation of triethylenetetramine disuccinate or triethylenetetramine tetrahydrochloride | TET1, TET2, TET3 | RECQL 2615/4885TP53 313/4885MDM2 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.